Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05446584 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

Study acronym: PATH
StatusRecruiting
PhasePhase 2
Started2023-04-20
View on ClinicalTrials.gov ↗

Amendment history

2026-07-16
3 amendments v5-v7
3 re-verifications since 2025-05-01, no change to tracked fields
2024-04-30
Study Status, Study Description, Arms and Interventions, Contacts/Locations v4
Study description-5 characters
[...] The three conditions are sham-control, active stimulation to left frontal region, and active stimulation to left temporal reg [...]
Study sitescontacts updated at 1 of 1 site
2023-05-05
Study Status, Oversight v3
Start dateestimated 2023-05-01→confirmed 2023-04-20
2023-04-13
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2026-08-31→2027-05-01
Completion date2027-08-31→2027-05-31
Study sitesdetails revised at 1 of 1 site
2023-04-03
Study Status v1
Primary completion date2026-05-31→2026-08-31
Completion date2026-08-31→2027-08-31
Start date2023-01-01→2023-05-01
2022-07-05
Original filing
This study will probe if the biological changes in amnestic mild cognitive impairment (aMCI) are related to a history of mild traumatic brain injury (mTBI) using high definition transcranial direct current stimulation (HD-tDCS) and blood-derived biomarker tools. Participants who Do as well as those who Do Not have a history of mTBI will be enrolled in the study.
Trial Details
NCT Number NCT05446584
Lead Sponsor University of Texas Southwestern Medical Center
Conditions Mild Cognitive Impairment, Amnestic Mild Cognitive Disorder, Amnestic Mild Cognitive Impairment, Mild Traumatic Brain Injury, Concussion, Brain
Enrollment 75 participants
Start Date 2023-04-20
Primary Completion 2027-05-01 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-20